BAS.DE - BASF SE

XETRA - XETRA Delayed Price. Currency in EUR
57.43
+2.03 (+3.66%)
At close: 5:35PM CEST
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close55.40
Open56.00
Bid57.03 x 139300
Ask57.07 x 16500
Day's Range55.90 - 58.04
52 Week Range37.35 - 72.17
Volume8,162,350
Avg. Volume6,088,104
Market Cap52.748B
Beta (5Y Monthly)1.26
PE Ratio (TTM)5.80
EPS (TTM)9.90
Earnings DateJul 29, 2020
Forward Dividend & Yield3.30 (5.96%)
Ex-Dividend DateJun 19, 2020
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • EPA must revoke its approval of widely used herbicide, court rules
      MarketWatch

      EPA must revoke its approval of widely used herbicide, court rules

      The federal government must revoke its approval of a widely used weed killer that has damaged other crops and turned neighbor against neighbor in some farm communities, a federal appeals court in California ruled.

    • Bayer Faces More Weedkiller Woes as U.S. Court Bans Dicamba
      Bloomberg

      Bayer Faces More Weedkiller Woes as U.S. Court Bans Dicamba

      (Bloomberg) -- Bayer AG is blocked from selling its controversial dicamba-based herbicide in the U.S. after an appeals court rejected a federal regulator’s permit for the product, compounding the German company’s weed-killer woes.The three-judge panel concluded the Environmental Protection Agency had “failed entirely” to acknowledge some risks dicamba poses and that the agency violated federal regulations when it extended its approval of registration for the herbicide for another two years in October 2018.The court, citing the EPA, said the decision could spur farmers to buy alternative seeds and pesticides. Weed killers can’t be sold or distributed in the U.S. without EPA registration. The decision is the latest blow to Bayer in the wake of its $63 billion takeover of Monsanto -- a deal that made the German company a leader in agriculture products but also saddled it with a mountain of legal liabilities related to weed killers.“We strongly disagree with the ruling and are assessing our options,” Bayer spokesman Chris Loder said in an email. “If the ruling stands, we will work quickly to minimize any impact on our customers this season.”Bayer shares fell 3.9% in Frankfurt trading Thursday. The company doesn’t break down sales of individual products or their active substances and declined to comment on sales at stake. BASF SE, which also makes dicamba, declined 0.3%.‘Day of Reckoning’George Kimbrell, of the Center for Food Safety and a lawyer in the case, called the ruling “a massive win for the farmers and the environment.”“It is good to be reminded that corporations like Monsanto and the Trump Administration cannot escape the rule of law, particularly at a time of crisis like this,” Kimbrell said in an email. “Their day of reckoning has arrived.”U.S. Secretary of Agriculture Sonny Perdue on Thursday called the ruling unfortunate, saying it eliminates one of the tools needed by food producers.“Farmers across America have spent hard earned money on previously allowed crop protection tools,” he said in a statement. “I encourage the EPA to use any available flexibilities to allow the continued use of already purchased dicamba products.”A less volatile formulation of dicamba was originally manufactured by Monsanto after its blockbuster weed-killer Roundup began losing its effectiveness, and farmers had to increasingly deal with resistant “super weeds.”Dicamba is a central ingredient in Bayer’s XtendiMax, and can vaporize after being applied to crops and drift onto neighboring fields that aren’t resistant to the herbicide. It’s widely blamed for damaging 3.6 million acres of untreated soybeans in 2017, and more than 1 million acres in 2018.The EPA “substantially understated risks that it acknowledged” concerning dicamba’s use, the appeals court said. The ruling applies to other dicamba-based herbicides produced by BASF and Corteva Agriscience.“EPA is currently reviewing the court decision and will move promptly to address the court’s directive,” a spokesperson for the agency said.Sales HitBASF will probably lose about 80 million to 90 million euros in sales for the rest of this year ($90 million to $101 million) via its Engenia herbicide, which contains dicamba, Sebastian Bray, an analyst at Berenberg, said by email. That revenue hit will be bigger at Bayer, which also sells seeds tied to dicamba, Bray said.Dicamba will probably stay banned even if this ruling gets appealed, Bray said. Still, the EPA will probably re-authorize dicamba in a revised form in time for next year -- and the agency could even move up that reauthorization before Dec. 20, when the current clearance was set to expire, Bray said.“We are reviewing the opinion, its impact on our FeXapan registration, and our next steps,” Gregg Schmidt, a spokesman for Corteva, said in an email.BASF said in a statement that the ruling will have a “significant adverse impact” on growers who have already purchased dicamba products for this season. The Ludwigshafen, Germany-based company disagrees with the decision and is considering its options to respond.In the first lawsuit over dicamba crop damage to go to trial, a jury in February hit Bayer and BASF with a $265 million damage award to a Missouri farmer who blamed the companies for destroying his peach orchards. Bayer is challenging the verdict.There are about 140 dicamba suits in total, and settling them could cost Bayer and BASF less than $1.5 billion, Holly Froum, an analyst with Bloomberg Intelligence, said in a note Thursday.In its ruling Wednesday, the appeals court acknowledged the “practical effects” of the decision, including the cost to farmers who have already purchased soybean and cotton seeds genetically modified to withstand dicamba and planted for the purpose of using the herbicide.The court quoted the EPA saying that voiding the dicamba registration “could leave those growers with an unusable pesticide technology system and force them to expend additional money on alternative seeds and pesticides.”The judges said in addition to the environmental risks, the EPA’s registration decision on dicamba failed to recognize the “enormous social cost to farming communities” where the herbicide’s use “has turned farmer against farmer, and neighbor against neighbor.” A farmer in Arkansas was shot and killed in an argument over dicamba damage in 2016, according to the ruling.The ruling applies to the 2018 dicamba registration, which expires in December, Loder said, adding that Bayer is working on a new EPA registration for the 2021 growing season and beyond.The case is National Family Farm Coalition v. U.S. Environmental Protection Agency, 19-70115, U.S. Court of Appeals for the Ninth Circuit (San Francisco).(Updates with U.S. Secretary of Agriculture’s comments)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

    • Reuters

      U.S. court blocks sales of Bayer's dicamba herbicide

      German agrochemicals group Bayer AG has been blocked from selling its dicamba herbicide in the United States after an appeals court rejected a federal regulator's permit for the product. The U.S. Appeals Court said on Wednesday that the U.S. Environmental Protection Agency (EPA) substantially understated the herbicide-related risks and entirely failed to look into other risks related to dicamba. Bayer said it strongly disagreed with the ruling.

    • Reuters

      RPT-U.S. senators weigh additional sanctions on Russia's Nord Stream 2

      Two U.S. senators said on Wednesday they could draft further sanctions on Russia's Nord Stream 2 natural gas pipeline if Moscow finishes laying pipes for the project. U.S. sanctions legislation originally sponsored by Senators Ted Cruz, a Republican, and Jeanne Shaheen, a Democrat, in December halted work by Swiss-Dutch company Allseas on the pipeline that aims to boost Russia's gas exports under the Baltic Sea to Germany. The pipeline, aimed at bypassing Ukraine, could be launched by the end of 2020 or early next year, Russian President Vladimir Putin has said.

    • Reuters

      U.S. senators weigh additional sanctions on Russia's Nord Stream 2

      Two U.S. senators said on Wednesday they could draft further sanctions on Russia's Nord Stream 2 natural gas pipeline if Moscow finishes laying pipes for the project. U.S. sanctions legislation originally sponsored by Senators Ted Cruz, a Republican, and Jeanne Shaheen, a Democrat, in December halted work by Swiss-Dutch company Allseas on the pipeline that aims to boost Russia's gas exports under the Baltic Sea to Germany. The pipeline, aimed at bypassing Ukraine, could be launched by the end of 2020 or early next year, Russian President Vladimir Putin has said.

    • Reuters

      Printing ink maker Flint nears debt deal ahead of planned sale -sources

      The world's second-largest printing ink maker, Flint Group, is nearing a debt deal seen as a pre-condition to proceed with a sales process that its owners launched last year, people close to the matter said. Flint Group has seen its supply chains affected and sales decrease during the coronavirus pandemic and expects its 2020 earnings before interest, tax, depreciation and amortization to fall from the 266 million in 2019, the sources said. The company, owned by Goldman Sachs' private equity arm and U.S.-based conglomerate Koch Industries, has engaged with its lenders to put its financing on a new footing, the people said.

    • Reuters

      German chemicals industry sees coronavirus hitting 2020 revenue

      German chemicals association VCI on Wednesday said it expected production and revenues in the chemical and pharmaceutical sectors to drop this year, citing declining orders and supply chains disrupted by the coronavirus pandemic. Christian Kullmann, president of the association that represents chemical and pharmaceutical firms with operations in Germany, said: "2020 will be a difficult year."

    • Thomson Reuters StreetEvents

      Edited Transcript of BAS.DE earnings conference call or presentation 30-Apr-20 7:00am GMT

      Q1 2020 BASF SE Earnings Press Conference

    • Reuters

      EU to halve pesticides by 2030 to protect bees, biodiversity - draft

      The European Commission is seeking to halve the use of chemical pesticides by 2030 to halt the decline of pollinators, in a plan likely to draw criticism both from those urging a phase-out of the substances and from farmers who say crop yields will suffer. The Commission, the EU executive, wants to commit the European Union to a halving of the use of chemical and "high-risk" pesticides by 2030, a draft document seen by Reuters and set to be published on May 20 showed. Beekeepers in western Europe have reported a fall in the number of bees and colony losses over the last 15 years, the European Food Safety Authority said.

    • Moody's

      Wintershall Dea Finance B.V. -- Moody's changes Wintershall Dea's outlook to negative, affirms the Baa2 rating

      Moody's Investors Service, ("Moody's") changed today the rating outlook for Wintershall Dea GmbH (Wintershall Dea) to negative from stable. Moody's also affirmed Wintershall Dea's ratings, including its Baa2 issuer rating and the Baa2 instrument ratings on the group's senior unsecured bank credit facilities.

    • Reuters

      Germany tasks its big international companies with procurement challenge

      German companies with international experience and supply chains have been commissioned to help the government procure difficult-to-obtain supplies as part of the country's response to the coronavirus crisis, a government document showed. Essential equipment like protective masks are in short supply around the world due to the spike in demand caused by the pandemic.

    • Moody's

      Brazoria County Brazos River Hrbr. Nav. Dist. -- Moody's places BASF's A2/P-1 ratings on review for downgrade

      Moody's Investors Service ("Moody's") has today placed the A2 senior unsecured notes ratings and (P)A2 senior unsecured MTN programme ratings of BASF (SE) (BASF or "the company") and its guaranteed subsidiary BASF Finance Europe NV on review for downgrade. It has also placed on review for downgrade the A2 unsecured rating of revenue bonds guaranteed by BASF.

    • North America farm suppliers race COVID-19 spread for planting season
      Reuters

      North America farm suppliers race COVID-19 spread for planting season

      WINNIPEG, Manitoba/CHICAGO, March 26 (Reuters) - North America's biggest farm suppliers are accelerating shipments of fertilizer, seeds and agricultural chemicals to crop-growing regions in an unprecedented race against the coronavirus that threatens to disrupt planting season. The timing could not be worse for farmers preparing to plant crops. Disruptions in deliveries of fertilizer, seeds or chemicals could reduce harvests and incomes for U.S. farmers who were hoping this year to sell more crops to China under the terms of a trade agreement signed in January.

    • Moody's

      DIC Corporation -- Moody's assigns Ba1 CFR to DIC Corporation and withdraws Baa3 issuer rating; outlook stable

      Moody's Japan K.K. has assigned a Ba1 corporate family rating (CFR) to DIC Corporation and has withdrawn the company's Baa3 issuer rating. More specifically, the weaknesses in DIC's credit profile, including its exposure to end markets, such as automotive and electronics, has left it vulnerable to shifts in these unprecedented operating conditions, and DIC remains vulnerable to continuing impact from the spread. Moody's regards the coronavirus outbreak as a social risk under its ESG framework, given the substantial implications for public health and safety.

    • Bayer's top seed faces U.S. soybean challenge from Corteva
      Reuters

      Bayer's top seed faces U.S. soybean challenge from Corteva

      CHICAGO/WINNIPEG, Manitoba (Reuters) - Bayer AG's takeover of Monsanto has been beset by problems, and now a decades-long dominance of the $4 billion U.S. soybean seed market is under threat from rival Corteva Inc. Bayer <BAYGn.DE> told Reuters it expects plantings of its genetically modified Xtend soybean seeds to flatline this year for the first time, after three years of strong growth since their launch with an accompanying weed-killer. Meanwhile Corteva <CTVA.N>, formed last year from the agricultural units of Dow Chemical and DuPont, expects its Enlist E3 seed to make up 20% of the U.S. crop in 2020, the first year it has been widely available.

    • FOCUS-Bayer's top seed faces U.S. soybean challenge from Corteva
      Reuters

      FOCUS-Bayer's top seed faces U.S. soybean challenge from Corteva

      CHICAGO/WINNIPEG, Manitoba, March 4 (Reuters) - Bayer AG's takeover of Monsanto has been beset by problems, and now a decades-long dominance of the $4 billion U.S. soybean seed market is under threat from rival Corteva Inc. Bayer told Reuters it expects plantings of its genetically modified Xtend soybean seeds to flatline this year for the first time, after three years of strong growth since their launch with an accompanying weed-killer.

    • BASF flags risk of lower earnings on virus hit
      Reuters

      BASF flags risk of lower earnings on virus hit

      Germany's BASF warned that earnings could drop further this year after the fallout from the coronavirus outbreak has started to weigh on demand from its industrial customers. The world's largest chemicals company by sales said on Friday that the virus heightened uncertainty in the global economy in January and February, and it does not expect trade conflicts between the United States and its trading partners to ease further. "The coronavirus has added a new factor that is considerably hampering growth at the beginning of the year, especially in China," said Martin Brudermueller, chief executive officer of BASF.

    • Bloomberg

      Europe's Coronavirus Plan Is Not Enough

      (Bloomberg Opinion) -- The economic damage from the Coronavirus epidemic has prompted calls for Europe to relax its fiscal rules to allow governments to cut taxes and increase spending. The European Commission seems to agree: Paolo Gentiloni, its economy tsar, has hinted that affected governments — such as Italy — may enjoy some budget “flexibility” to deal with the emergency.Granting more leeway is a welcome step, but it’s only a second-best approach. The virus risks affecting some countries much more than others. A centralized euro-zone budget would be a better way to address these localized difficulties, since it would allow the channeling of funds to countries where it was most needed. Some governments have much less fiscal space that others — think of Italy, which is struggling with the continent’s worst coronavirus outbreak. It’s unfortunate that a euro-area pot of money does not exist for this kind of eventuality; instead, some member states will be forced to borrow more even when they have very high levels of public debt.The impact from the Covid-19 on the euro zone isn’t yet visible in the macroeconomic data, but many businesses are warning that the impact will be severe. The chemicals giant BASF SE was the latest to do so, on Friday. Companies face a damaging combination of disruptions to their supply chains and a slowdown in demand — both from outside the single-currency area and from within. Europe’s stocks are tumbling and are set for their worst week since the region’s sovereign debt crisis in 2011.The virus has spread across Europe, but some nations are bearing a greater brunt. Italy has had to lock down two areas, home to about 50,000 people, where the country’s outbreak begun. The region of Lombardy, which produces an estimated 22% of the country’s gross domestic product, has taken draconian steps to contain the epidemic such as closing schools and other public spaces. Other northern regions have done the same. Ignazio Visco, governor of the Bank of Italy, believes the crisis could shed as much as one-quarter of a percentage point from this year’s growth rate.Rome is preparing a set of measures to help companies and workers hit by the crisis. The trouble is that Italy faces severe budget deficit limits, given its high public debt — which stands at about 135% of GDP. In 2018, Italy locked horns with Brussels, as it sought to push for borrowing levels that the Commission deemed excessive. The fear is that a fiscal stimulus to counter the slowdown might provoke a similar backlash if the Italians or anyone else are deemed to be spending recklessly.The Commission appears open-minded about giving Rome — and other countries in need — more leeway on their EU-imposed budgetary limits to support the economy. That’s wise. The euro zone has relied heavily on monetary policy to foster a recovery, so the European Central Bank has less room to act than in the past. Governments can tailor fiscal policy to their own country’s needs, depending on how the severity of the economic damage.However, a country’s ability to react will depend entirely on its own fiscal space. Germany will have greater room for maneuver —  if it chooses to act — than Spain or Italy because its debt is much lower. This is why the approach has serious shortcomings, since the virus will strike anywhere, regardless of a country’s economic situation (at least within the euro zone). The best tool to respond would be a central fiscal capacity, which distributes resources depending on a country’s needs.So far, the dream of a euro-area budget has proven elusive because thrifty countries such as Germany have feared other member states would squander the money. The “Budgetary Instrument for Convergence and Competitiveness”, which was agreed at the end of last year (though is not yet in place) is expected to be tiny, and in any event cannot be used to help countries deal with an economic shock. The coronavirus epidemic shows the limits of not having more meaningful instrument. It would be far better if countries chose to build an insurance mechanism to help each other, as recommended by the International Monetary Fund and Mario Draghi, former ECB president.It’s still possible that the damage from the Coronavirus will prove temporary, and that the euro zone will experience a “V-shaped” recovery. The ECB says it’s ready to step in, cutting rates further into negative territory if the slowdown is worse than feared.Europe’s politicians should sharpen their fiscal tools. It’s a pity they’re inadequate for this challenge.To contact the author of this story: Ferdinando Giugliano at fgiugliano@bloomberg.netTo contact the editor responsible for this story: James Boxell at jboxell@bloomberg.netThis column does not necessarily reflect the opinion of Bloomberg LP and its owners.Ferdinando Giugliano writes columns on European economics for Bloomberg Opinion. He is also an economics columnist for La Repubblica and was a member of the editorial board of the Financial Times.For more articles like this, please visit us at bloomberg.com/opinionSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

    • Benzinga

      Dollar Volume In GBTC More Than Doubled In January, As Coronavirus Fears Spurred A Crypto Rally

      Nearly $24 billion worth of shares traded on OTC Markets last month, down about 2% from December. There were a number of significant volume increases in individual securities throughout the month, with ...

    • Reuters

      European shares edge higher amid China support measures

      European shares inched higher on Monday as fresh attempts by China to limit the economic impact of the coronavirus outbreak helped calm investor nerves. The pan-European STOXX 600 index rose 0.3% in early trade, staying slightly below a record high of 432.26 touched last week. Market activity is expected to be light through the rest of the day on account of a U.S. holiday.

    • U.S. peach grower awarded $265 million from Bayer, BASF in weedkiller lawsuit
      Reuters

      U.S. peach grower awarded $265 million from Bayer, BASF in weedkiller lawsuit

      A jury in U.S. District Court in Cape Girardeau, Missouri, handed Bader, the state's largest peach farmer, $15 million in actual and $250 million in punitive damages. The three-week trial was the first case in the United States to rule on the use of dicamba-based herbicides alleged to have damaged tens of thousands of acres of U.S. cropland. The herbicide can become a vapor and drift for miles when used in certain weather, farmers have claimed.

    • Reuters

      Bayer to appeal $265 mln U.S. damages award on dicamba weedkiller

      German agrochemicals group Bayer said on Sunday it would appeal a U.S. jury's $265 million damages award against it and BASF in favour of a Missouri farmer who said the company's dicamba herbicide had destroyed his peach orchards. The jury award, the first of more than 140 dicamba cases to come to trial, is separate to multi-billion-dollar litigation Bayer is trying to settle over the Roundup weedkiller made by Monsanto, the U.S. firm it took over for $63 billion in 2018. Monsanto made both Roundup and dicamba, and Bayer is being sued over both products.